PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 57.15
-1.65 (-2.81%)
At close: Mar 27, 2026
PegBio Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
22.35B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 242.40K | 133.56K | 122.72% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genscript Biotech | 7.47B |
| Zai Lab | 3.58B |
| Shanghai Junshi Biosciences | 2.78B |
| InnoCare Pharma | 2.64B |
| Duality Biotherapeutics | 2.06B |
| Everest Medicines | 1.90B |
| Keymed Biosciences | 797.12M |
| Ascentage Pharma Group International | 638.89M |